157 related articles for article (PubMed ID: 28316053)
21. Tumour-derived plasma cell-free DNA in patients with head and neck cancer: A short review.
Rave-Fränk M
Cancer Radiother; 2017 Oct; 21(6-7):554-556. PubMed ID: 28847459
[TBL] [Abstract][Full Text] [Related]
22. Circulating tumour cell PD-L1 test for head and neck cancers.
Kulasinghe A; Kenny L; Punyadeera C
Oral Oncol; 2017 Dec; 75():6-7. PubMed ID: 29224824
[TBL] [Abstract][Full Text] [Related]
23. Total lymphocyte and T lymphocyte subpopulation levels in head and neck squamous cell carcinomas.
Soysal V; Yigitbasi OG; Alper M; Patiroglu T; Güney E
J Exp Clin Cancer Res; 1998 Jun; 17(2):207-12. PubMed ID: 9700582
[TBL] [Abstract][Full Text] [Related]
24. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
Cacicedo J; Fernandez I; Del Hoyo O; Dolado A; Gómez-Suarez J; Hortelano E; Sancho A; Pijoan JI; Alvarez J; Espinosa JM; Gaafar A; Bilbao P
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
[TBL] [Abstract][Full Text] [Related]
25. A liquid biopsy for head and neck cancers.
Schmidt H; Kulasinghe A; Perry C; Nelson C; Punyadeera C
Expert Rev Mol Diagn; 2016; 16(2):165-72. PubMed ID: 26631411
[TBL] [Abstract][Full Text] [Related]
26. Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.
Schmitz S; Machiels JP
Curr Treat Options Oncol; 2016 Jul; 17(7):37. PubMed ID: 27262711
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of serum alkaline DNase activity in treatment monitoring of head and neck cancer patients.
Patel PS; Patel BP; Rawal RM; Raval GN; Patel MM; Patel JB; Jha FP; Patel DD
Tumour Biol; 2000; 21(2):82-9. PubMed ID: 10686537
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of neutrophil gelatinase-associated lipocalin in head and neck squamous cell carcinoma correlated with tumorigenesis, not with metastasis.
Wang L; Chen C; Li F; Hua Q; Chen S; Xiao B; Dai M; Li M; Zheng A; Yu D; Hu Z; Tao Z
Int J Clin Exp Pathol; 2015; 8(8):8857-68. PubMed ID: 26464627
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
Wang Z; Cui K; Xue Y; Tong F; Li S
Med Oncol; 2015 May; 32(5):164. PubMed ID: 25895596
[TBL] [Abstract][Full Text] [Related]
31. Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).
Weller P; Nel I; Hassenkamp P; Gauler T; Schlueter A; Lang S; Dountsop P; Hoffmann AC; Lehnerdt G
PLoS One; 2014; 9(12):e113706. PubMed ID: 25479539
[TBL] [Abstract][Full Text] [Related]
32. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
33. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.
Kandiloros D; Eleftheriadou A; Chalastras T; Kyriou L; Yiotakis I; Ferekidis E
Med Oncol; 2006; 23(4):463-70. PubMed ID: 17303904
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
[TBL] [Abstract][Full Text] [Related]
35. CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker.
Banerjee J; Pradhan R; Gupta A; Kumar R; Sahu V; Upadhyay AD; Chaterjee P; Dwivedi S; Dey S; Dey AB
Clin Transl Oncol; 2017 May; 19(5):571-578. PubMed ID: 27815686
[TBL] [Abstract][Full Text] [Related]
36. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E
Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792
[TBL] [Abstract][Full Text] [Related]
37. Serum selenium levels in patients with head and neck cancer.
Yadav SP; Gera A; Singh I; Chanda R
J Otolaryngol; 2002 Aug; 31(4):216-9. PubMed ID: 12240756
[TBL] [Abstract][Full Text] [Related]
38. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
[TBL] [Abstract][Full Text] [Related]
39. Monocyte CD40 expression in head and neck squamous cell carcinoma (HNSCC).
Sathawane D; Kharat RS; Halder S; Roy S; Swami R; Patel R; Saha B
Hum Immunol; 2013 Jan; 74(1):1-5. PubMed ID: 23000501
[TBL] [Abstract][Full Text] [Related]
40. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D; Vendrell JJ; León X; Vilaseca I; Terra X
Head Neck; 2017 Dec; 39(12):2501-2511. PubMed ID: 28963801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
